Consumer believability of information in direct-to-consumer (DTC) advertising of prescription drugs

被引：27

作者：

Beltramini, RF ^{[1
]}

机构：

[1] Wayne State Univ, Sch Business Adm, Troy, MI 48098 USA

来源：

JOURNAL OF BUSINESS ETHICS | 2006年 / 63卷 / 04期

基金：

美国国家科学基金会;

关键词：

advertising effectiveness; believability; benefit-risk information balance; direct to consumer (DTC); patient-doctor relationship; public policy regulation; prescription drugs;

D O I：

10.1007/s10551-005-4711-2

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

Direct to consumer (DTC) advertising has attracted significant research attention, yet none has focused on empirical assessments of its overall impact on U.S. consumers nationally, and tying assessment to relevant behavioral outcomes. This paper addresses the ethical issue of DTC advertising providing a balance of product and risk information that is both understandable and believable, and contributes direction to those exploring this phenomenon.

引用

页码：333 / 343

页数：11

共 44 条

[31] *NAT HLTH COUNC, 2002, DIR CONS PRESCR DRUG
[32] Pines WL, 1999, FOOD DRUG LAW J, V54, P489
[33] A ROLE FOR CONSUMER BELIEF IN FTC AND LANHAM ACT DECEPTIVE ADVERTISING CASES
PRESTON, IL
RICHARDS, JI
[J]. AMERICAN BUSINESS LAW JOURNAL, 1993, 31 (01) : 1 - 29
[34] Richards J.I., 1990, DECEPTIVE ADVERTISIN
[35] *ROD PUBL, 1999, PREV MAG NAT SURV CO
[36] *ROD PUBL, 2001, 5 ANN SURV CONS REAC
[37] *ROD PUBL, 2000, PREV MAG INT SURV WE
[38] Consumers' attitudes and behavior toward prescription drug advertising
Sumpradit, N
Fors, SW
McCormick, L
[J]. AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2002, 26 (01) : 68 - 75
[39] *TIM INC, 2000, MEAS AW IMP DIR CONS
[40] *US GAO, 2002, PRESCR DRUGS FDA OV

← 1 2 3 4 5 →